Posts by: Ana Pena

News

Psychosis is a rare manifestation of systemic lupus erythematosus (SLE) that generally appears early, in the year before or within the first three years after SLE onset. The disorder ... Read more

October 12, 2018

Xencor’s Candidate Antibody Therapy for Lupus Shows Positive Results in Phase 2 Study

News

Xencor announced top-line results from its Phase 2 clinical trial testing the candidate antibody therapy XmAb5871 for the treatment of systemic lupus erythematosus (SLE). The antibody seems to help control or reduce lupus ... Read more

August 24, 2018August 24, 2018

Among Black Women, Smoking Linked with Increased Lupus Risk, Moderate Drinking with Less Risk, Study Reports

News

Smoking was found to be associated with an increased risk of systemic lupus erythematosus (SLE) among black women, while moderate alcohol consumption significantly reduces the chances of developing the disease, ... Read more

July 11, 2018July 11, 2018

Neovacs’ Investigational Lupus Vaccine Shows Positive Results in Phase 2b Trial

News

IFN-alpha Kinoid, an investigational vaccine by Neovacs, has a favorable safety profile and showed encouraging signs of effectiveness in systemic lupus erythematosus (SLE) patients, according to results from a Phase 2b clinical ... Read more

June 18, 2018

Lower Testosterone Levels May Be Linked to Greater Lupus Risk in Women, Study Finds

News

Lower testosterone levels might be the reason behind why women are at a higher risk than men of developing autoimmune diseases like lupus, new research suggests. Using animal models, ... Read more

May 7, 2018

New Pathway Behind Lupus and Autoimmunity Discovered in Animal Study

News

A new mechanism that helps to maintain immune self-tolerance and prevent autoimmune diseases was discovered using human cells and mice, new research shows. The findings identify a novel pathway ... Read more

April 25, 2018

Epstein-Barr Infection Raises Risk of Lupus, 6 Other Autoimmune Diseases, Study Suggests

News

Infection with the Epstein-Barr virus (EBV) that causes mononucleosis can increase a person’s risk of developing any of seven major autoimmune diseases, including systemic lupus erythematosus, new and possibly ... Read more

April 13, 2018April 13, 2018

Lenabasum, Investigational Therapy for Lupus, Advances to Phase 2 Clinical Trial

News

A Phase 2 clinical trial testing a Corbus Pharmaceuticals’ synthetic cannabinoid derivative – lenabasum (JBT-101) – for lupus patients is underway. The therapy has no psychotropic properties and is intended ... Read more

This is a short description about myself and what this site is about. I hope you enjoy being here!

Posts by: Ana Pena

Ana Pena

Psychosis Is a Rare But Treatable Lupus Manifestation, Large International Study Shows

Xencor’s Candidate Antibody Therapy for Lupus Shows Positive Results in Phase 2 Study

Among Black Women, Smoking Linked with Increased Lupus Risk, Moderate Drinking with Less Risk, Study Reports

Neovacs’ Investigational Lupus Vaccine Shows Positive Results in Phase 2b Trial

Lower Testosterone Levels May Be Linked to Greater Lupus Risk in Women, Study Finds

New Pathway Behind Lupus and Autoimmunity Discovered in Animal Study

Epstein-Barr Infection Raises Risk of Lupus, 6 Other Autoimmune Diseases, Study Suggests

Lenabasum, Investigational Therapy for Lupus, Advances to Phase 2 Clinical Trial

Pin It on Pinterest